The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia.
Saudi Pharm J
; 30(10): 1448-1453, 2022 Oct.
Article
en En
| MEDLINE
| ID: mdl-36387341
DAA, direct-acting antiviral agent; DSV, dasabuvir; Direct-acting antivirals; Effectiveness; GT, genotype; Genotype 4; HCV, hepatitis C virus; Hepatitis C virus; LDV, ledipasvir; OBV, ombitasvir; PTV, paritaprevir; RBV, ribavirin; SOF, sofosbuvir; Saudi population; Sustained virologic response; r, ritonavir
Texto completo:
1
Colección:
01-internacional
Base de datos:
MEDLINE
Tipo de estudio:
Guideline
/
Observational_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Saudi Pharm J
Año:
2022
Tipo del documento:
Article
País de afiliación:
Arabia Saudita
Pais de publicación: